Skip to main content
Premium Trial:

Request an Annual Quote

Ivan Richards

Premium

Sirna Therapeutics said this week that it has appointed Ivan Richards as senior director of pharmacology.

Richards joins Sirna from Pfizer, where he was responsible for preclinical drug discovery activities, including pharmacology, drug metabolism, and toxicology. He received a PhD in pharmacology from the Royal College of Surgeons and has published numerous scientific papers, said Sirna.

“As Sirna moves forward in selecting specific lead RNAi compounds, Ivan’s valuable drug discovery and development experience will help drive the advancement of these product candidates toward clinical trials,” Sirna president and CEO Howard Robin in a statement.

The Scan

Highly Similar

Researchers have uncovered bat viruses that are highly similar to SARS-CoV-2, according to Nature News.

Gain of Oversight

According to the Wall Street Journal, the Biden Administration is considering greater oversight of gain-of-function research.

Lasker for mRNA Vaccine Work

The Scientist reports that researchers whose work enabled the development of mRNA-based vaccines are among this year's Lasker Award winners

PLOS Papers on Causal Variant Mapping, Ancient Salmonella, ALK Fusion Test for NSCLC

In PLOS this week: MsCAVIAR approach to map causal variants, analysis of ancient Salmonella, and more.